Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues.
Gut
; 65(2): 313-20, 2016 Feb.
Article
in En
| MEDLINE
| ID: mdl-25586058
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Interferon-alpha
/
Hepatitis B, Chronic
/
Seroconversion
/
Hepatitis B Antibodies
/
Hepatitis B e Antigens
/
Nucleosides
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
En
Journal:
Gut
Year:
2016
Type:
Article
Affiliation country:
China